|1.||Pastan, Ira: 6 articles (11/2015 - 01/2007)|
|2.||Hassan, Raffit: 4 articles (11/2011 - 01/2007)|
|3.||Paik, Chang H: 2 articles (11/2015 - 11/2011)|
|4.||Grasso, Luigi: 2 articles (11/2015 - 01/2007)|
|5.||Yao, Zhengsheng: 2 articles (11/2015 - 11/2011)|
|6.||Schweizer, Charles: 2 articles (12/2010 - 06/2010)|
|7.||Kim, Heejung: 1 article (11/2015)|
|8.||Lee, Jae-Ho: 1 article (11/2015)|
|9.||Szajek, Lawrence P: 1 article (11/2015)|
|10.||Lee, Sung-Jin: 1 article (11/2015)|
11/01/2011 - "This study demonstrates that the number of chelate conjugation and the injected dose are two important parameters to achieve high tumor and low non-target organ uptake of (111)In-labeled MORAb-009. "
11/01/2011 - "The biodistribution studies also revealed that the tumor uptake was significantly affected by the injected MORAb-009 dose and tumor size. "
11/01/2011 - "The (111)In-labeled MORAb-009 conjugated with 2.4 CHX-A″ produced higher tumor uptake and lower liver and spleen uptakes than the 5.5 CHX-A″ conjugate. "
11/01/2015 - "To investigate the effect of the injection dose of MORAb-009 (amatuximab, an anti-mesothelin monoclonal antibody), the tumor size and the level of shed mesothelin on the uptake of the antibody in mesothelin-positive tumor and organs by biodistribution (BD) and positron emission tomography (PET) imaging studies. "
11/01/2015 - "Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies."
06/01/2010 - "This report summarizes the effect of MORAb-009 on serum CA-125 kinetics in the eight patients with mesothelioma who had CA-125 levels measured before and at different time-points following therapy. "
12/15/2010 - "MORAb-009 is a chimeric monoclonal antibody that targets mesothelin, a tumor differentiation antigen overexpressed in pancreatic cancer, ovarian cancer, mesothelioma, and other malignancies. "
|4.||Pancreatic Neoplasms (Pancreatic Cancer)
|5.||Ovarian Neoplasms (Ovarian Cancer)
|1.||megakaryocyte potentiating factor
|2.||Drug Therapy (Chemotherapy)